Cargando…
PARP Inhibitors in Combination with Radiotherapy: To Do or Not to Do?
SIMPLE SUMMARY: Despite the large use of inhibitors of Poly-ADP ribose polymerase (PARP-I), the feasibility and safety of their combination with radiotherapy (RT) are unclear. The combination may be particularly interesting in the oligometastatic setting in which patients may benefit from local RT d...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582502/ https://www.ncbi.nlm.nih.gov/pubmed/34771545 http://dx.doi.org/10.3390/cancers13215380 |